Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine for Oxidative Stress in Hemodialysis
NCT00247507Phase 4Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of acetylcysteine in anemia, atherosclerosis, oxidative stress and 1 more, sponsored by Far Eastern Memorial Hospital. Primary endpoints: plasma oxidized low-density lipoprotein levels at 12 weeks and Anemia status at 12 weeks. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
anemiaatherosclerosisoxidative stressinflammation
Beyond the preview
Go deeper on NCT00247507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00247507.